| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CDTX | Common Stock | 26,369 | 09 Jul 2021 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CDTX | Stock Option (right to buy) | 09 Jul 2021 | Common Stock | 12,111 | $2.45 | Direct | F1 | ||||||
| holding | CDTX | Stock Option (right to buy) | 09 Jul 2021 | Common Stock | 20,012 | $2.45 | Direct | F2 | ||||||
| holding | CDTX | Stock Option (right to buy) | 09 Jul 2021 | Common Stock | 6,700 | $1.98 | Direct | F3 | ||||||
| holding | CDTX | Stock Option (right to buy) | 09 Jul 2021 | Common Stock | 12,150 | $2.55 | Direct | F4 | ||||||
| holding | CDTX | Restricted Stock Unit | 09 Jul 2021 | Common Stock | 524 | Direct | F5, F6 |
| Id | Content |
|---|---|
| F1 | One-third (1/3) of the shares subject to the option vested on December 18, 2020 and the remainder vests and becomes exercisable in a series of twenty-four (24) successive equal monthly installments thereafter until fully vested on December 18, 2022. |
| F2 | Shares are fully vested |
| F3 | The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 19, 2020. |
| F4 | The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 17, 2021. |
| F5 | The shares shall vest upon the achievement of various clinical and corporate milestones. |
| F6 | Restricted stock units convert into common stock on a one-for-one basis. |